The need for continued monitoring of antibiotic resistance patterns in clinical isolates of Staphylococcus aureus from London and Malta

Table 2 Illustrates the predominant multiple antibiotic resistant (MAR) profiles identified in the MRSA isolates from the LBH and Malta

Multiple antibiotic-resistant (MAR) profiles	Percentage (%) of isolates showing the indicated resistance pattern.
	LBH (n = 256)	Malta (n = 216)
AK, G, PG, M, CD, E, Clar, Cip	5.1	-
Ak, PG, M, C, CD, E, Clar, Cip	4.7	-
Ak, PG, M, CD, E, Clar, Cip	4.3	-
G, PG, M, CD, E, Clar, Cip	12.8	-
PG, M, C, CD, E, Clar, Cip	8.2	20.8
PG, M, CD, E, Clar, Cip	31.1	21.8
PG, M, Cip	-	5.6

AK: amikacin; C: chloramphenicol; Cip: ciprofloxacin; Clar: clarithromycin; CD: clindamycin; E: erythromycin; G: genatmicin; M: methicillin and PG: penicillin G.

ISSN: 1476-0711